Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health Systems

Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health Systems

Clinical criteria/Family history-based <i>BRCA</i> testing misses a large proportion of <i>BRCA</i> carriers who can benefit from screening/prevention. We estimate the cost-effectiveness of population-based <i>BRCA</i> testing in general population women across di...

Full description

Bibliographic Details
Main Authors: Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof, Rosa Legood
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
BRCA
population testing
cost-effectiveness
ovarian cancer
breast cancer
cancer prevention
Online Access:https://www.mdpi.com/2072-6694/12/7/1929

Similar Items

Similar Items